Effect of gastric bypass on glucose reduction and glucagon-like peptide-1 secretion of rats with type 2 diabetes
Xing Bao, Min Du, Jing-yu Dai, Jie Zhang
Abstract
Xing Bao, Min Du, Jing-yu Dai, Jie Zhang
Abstract
Objective To investigate the effect of gastric bypass (GBP) on rats with type 2 diabetes induced by streptozotocin (STZ) injection and the action mechanisms involved.Methods Twenty rats were divided into 4 groups:operation group (group O,n =18),sham operation group (group S,n =15),food control group (group F,n =15) and control group (group C,n =15).Weight,fasting blood glucose (FBG),fasting plasma insulin (FPI) and glucagon-like peptide-1 (GLP-1) were measured 1,2,4 and 8 weeks after operation.Results (1) FBG in O group 8 weeks after operation was reduced to (8.2 ±2.4) mmol/L (P < 0.05) ; (2) FPI in O group was increased after operation and reached (72.5 ±7.4) mU/L at week 8 was compared with that before operation [(29.1 ± 5.1) mU/L] ; (3) GLP-1 in O Group at 8th week after operation was increased to (23.26 ± 2.19) pmoL/L(P <0.05).Conclusion GBP was an effective therapy to control blood glucose in type 2 diabetic rats and lead to high secretion of GLP-1.There is no significant relation between decreased blood glucose in type 2 diabetic rats with restricted diet and weight loss after GBP. Key words: Gastric bypass; Type 2 diabetic; Glucagon-like peptide-1
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect of gastric bypass (GBP) on rats with type 2 diabetes induced by streptozotocin (STZ) injection and the action mechanisms involved.Methods Twenty rats were divided into 4 groups:operation group (group O,n =18),sham operation group (group S,n =15),food control group (group F,n =15) and control group (group C,n =15).Weight,fasting blood glucose (FBG),fasting plasma insulin (FPI) and glucagon-like peptide-1 (GLP-1) were measured 1,2,4 and 8 weeks after operation.Results (1) FBG in O group 8 weeks after operation was reduced to (8.2 ±2.4) mmol/L (P < 0.05) ; (2) FPI in O group was increased after operation and reached (72.5 ±7.4) mU/L at week 8 was compared with that before operation [(29.1 ± 5.1) mU/L] ; (3) GLP-1 in O Group at 8th week after operation was increased to (23.26 ± 2.19) pmoL/L(P <0.05).Conclusion GBP was an effective therapy to control blood glucose in type 2 diabetic rats and lead to high secretion of GLP-1.There is no significant relation between decreased blood glucose in type 2 diabetic rats with restricted diet and weight loss after GBP. Key words: Gastric bypass; Type 2 diabetic; Glucagon-like peptide-1
Key concepts: Internal medicine, Endocrinology, Medicine, Type 2 diabetes, Glucagon-like peptide-1, Gastric bypass, Glucagon, Insulin